老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

0.8200
-0.0300-3.53%
盤前：0.82000.00000.00%05:57 EDT
成交量：17.41萬
成交額：14.73萬
市值：287.25萬
市盈率：-0.03
高：0.8803
開：0.8600
低：0.8130
收：0.8500
52周最高：60.00
52周最低：0.8130
股本：350.31萬
流通股本：125.01萬
量比：0.77
換手率：13.93%
股息：- -
股息率：- -
每股收益(TTM):-32.4560
每股收益(LYR):-371.2241
淨資產收益率：-126.98%
總資產收益率：-62.31%
市淨率：0.29
市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告
2021/01/11

重要事件披露

8-K - Current report
2020/12/30

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/03

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多